The Longevity Clinic team attended the 2026 National Alzheimer's Conference, where the latest findings on neurodegenerative prevention and the role of genetics in risk assessment were presented.
This article summarizes the main topics discussed at the conference and explains what these findings mean for patients seeking a personalized neurodegenerative risk evaluation.
The full content will be added by the clinic's team.